BRIGHTMEDS GLP-1: A DEEP LOOK INTO THIS INNOVATIVE THERAPY

GLP-1 receptor agonists , particularly those like BrightMeds, are increasingly prominence in the management of type 2 diabetes and are increasingly explored for obesity . These powerful drugs help mimicking the body's natural incretin hormone , stimulating glucose-dependent insulin secretion and